CVS Health announces post-merger leadership change, new board members
On the heels of getting the green light from the U.S. Department of Justice to acquire health insurer Aetna, CVS Health appointed a new CFO, as well as three new board members.
Following the completion of the transaction, Eva Boratto will become executive VP and CFO of CVS Health. She is currently CVS Health's executive VP, controller and chief accounting officer. She will replace Shawn M. Guertin, who has decided to step away for personal and family reasons. Guertin, Aetna’s executive VP, CFO and chief enterprise risk officer, was named CVS Health executive VP and CFO in June. Guertin will remain with CVS Health until June 2019 to help the combined company with integration and financial planning strategy. As previously disclosed, Aetna will be managed as a distinct operating entity within the CVS Health organization.
Boratto’s financial background spans more than 20 years, and includes senior positions in both the pharmaceutical manufacturing and PBM industries, along with other health care finance roles. She joined CVS Health in 2010 as senior VP, PBM finance, and later moved into her current role.
Prior to joining CVS Health, Boratto served in a number of executive positions at Merck & Co., including VP, U.S. market finance leader, with responsibility for financial oversight of Merck's U.S. pharmaceutical market, and VP, investor relations.
CVS Health is also bolstering its board of directors. Following the merger, Edward Ludwig, Fernando Aguirre, and Roger Farah will join the CVS Health board.
Farah joined the Aetna board in 2007, chairs the compensation and talent management committee, and is a member of the executive and investment and finance committees. Aguirre joined Aetna’s board in 2011, chairs the nominating and corporate governance committee, and is a member of the executive and audit committees.
These executives, along with Mark Bertolini, Aetna's current chairman and CEO, will bring the total number of CVS Health Board members to 16, according to the company.
Following the completion of the transaction, Eva Boratto will become executive VP and CFO of CVS Health. She is currently CVS Health's executive VP, controller and chief accounting officer. She will replace Shawn M. Guertin, who has decided to step away for personal and family reasons. Guertin, Aetna’s executive VP, CFO and chief enterprise risk officer, was named CVS Health executive VP and CFO in June. Guertin will remain with CVS Health until June 2019 to help the combined company with integration and financial planning strategy. As previously disclosed, Aetna will be managed as a distinct operating entity within the CVS Health organization.
Boratto’s financial background spans more than 20 years, and includes senior positions in both the pharmaceutical manufacturing and PBM industries, along with other health care finance roles. She joined CVS Health in 2010 as senior VP, PBM finance, and later moved into her current role.
Prior to joining CVS Health, Boratto served in a number of executive positions at Merck & Co., including VP, U.S. market finance leader, with responsibility for financial oversight of Merck's U.S. pharmaceutical market, and VP, investor relations.
CVS Health is also bolstering its board of directors. Following the merger, Edward Ludwig, Fernando Aguirre, and Roger Farah will join the CVS Health board.
Farah joined the Aetna board in 2007, chairs the compensation and talent management committee, and is a member of the executive and investment and finance committees. Aguirre joined Aetna’s board in 2011, chairs the nominating and corporate governance committee, and is a member of the executive and audit committees.
These executives, along with Mark Bertolini, Aetna's current chairman and CEO, will bring the total number of CVS Health Board members to 16, according to the company.